Contact: Barbara Fornasiero, EAFocus, Inc. 248.260.8466 email@example.com
Ann Arbor, Mich.–January 4, 2017—Brinks Gilson & Lione, one of the nation’s largest intellectual property law firms, announced that four attorneys in the firm’s Ann Arbor office have been named by their peers as Leading Lawyers in Michigan for 2016-2017. They are Shareholders William Boudreaux, James Cleland and Michael Spink, and Counsel Mike Gzybowski. The Michigan Leading Lawyers publication is included as an insert in the recently released Crain’s Detroit Business 2017 Book of Lists.
Boudreaux was recognized in the categories of biotechnology law and intellectual property law; both Cleland and Spink were noted for intellectual property law, copyright and trademark law and patent law; Gzybowski was noted for intellectual property law and patent law. At Brinks, Boudreaux is co-chair of the Biotechnology & Pharmaceuticals Industry Practice Group and Spink is chair of the Licensing Group and the Intellectual Asset Management Group.
Brinks’ Ann Arbor office is one of the firm’s seven offices in the U.S. The firm is celebrating its 100th anniversary in 2017.
About Leading Lawyers
Leading Lawyers, a division of the Law Bulletin Publishing Company, surveys thousands of attorneys statewide to identify lawyers most often recommended by their peers. Lawyers cannot nominate themselves or anyone at their own law firm. Fewer than five percent of all lawyers licensed to practice law in a given state can be named a Leading Lawyer. Learn more at www.leadinglawyers.com.
Brinks Gilson & Lione
Celebrating its centennial year in 2017, Brinks Gilson & Lione is one of the largest intellectual property law firms in the US, and helps clients around the world to protect and enforce their intellectual property rights. Our more than 140 lawyers, patent agents and scientific advisors assist clients in all aspects of patent, trademark, unfair competition, trade secret, and copyright law. Brinks attorneys provide informed counsel with respect to innovations in a range of complex and valuable technologies, including pharmaceuticals, chemicals, bioengineering, industrial manufacturing, electronics and software, and medical devices. More information is at www.brinksgilson.com.
# # #